Kyung Nam Pharm Statistics

Total Valuation

Kyung Nam Pharm has a market cap or net worth of KRW 56.03 billion. The enterprise value is 47.33 billion.

Market Cap	56.03B
Enterprise Value	47.33B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Kyung Nam Pharm has 78.15 million shares outstanding. The number of shares has increased by 52.38% in one year.

Current Share Class	78.15M
Shares Outstanding	78.15M
Shares Change (YoY)	+52.38%
Shares Change (QoQ)	+16.51%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	42.39M

Valuation Ratios

The trailing PE ratio is 5.83.

PE Ratio	5.83
Forward PE	n/a
PS Ratio	1.00
PB Ratio	0.49
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	93.25
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.39, with an EV/FCF ratio of -7.21.

EV / Earnings	4.93
EV / Sales	0.84
EV / EBITDA	17.39
EV / EBIT	71.15
EV / FCF	-7.21

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.31.

Current Ratio	1.76
Quick Ratio	1.43
Debt / Equity	0.31
Debt / EBITDA	13.37
Debt / FCF	-5.44
Interest Coverage	0.48

Financial Efficiency

Return on equity (ROE) is -3.29% and return on invested capital (ROIC) is 0.27%.

Return on Equity (ROE)	-3.29%
Return on Assets (ROA)	0.24%
Return on Invested Capital (ROIC)	0.27%
Return on Capital Employed (ROCE)	0.51%
Revenue Per Employee	231.21M
Profits Per Employee	39.54M
Employee Count	243
Asset Turnover	0.35
Inventory Turnover	3.11

Taxes

In the past 12 months, Kyung Nam Pharm has paid 676.63 million in taxes.

Income Tax	676.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.14% in the last 52 weeks. The beta is 0.45, so Kyung Nam Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-0.14%
50-Day Moving Average	697.10
200-Day Moving Average	659.10
Relative Strength Index (RSI)	46.13
Average Volume (20 Days)	3,597,533

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kyung Nam Pharm had revenue of KRW 56.18 billion and earned 9.61 billion in profits. Earnings per share was 149.55.

Revenue	56.18B
Gross Profit	15.52B
Operating Income	613.15M
Pretax Income	-2.62B
Net Income	9.61B
EBITDA	2.67B
EBIT	613.15M
Earnings Per Share (EPS)	149.55

Full Income Statement

Balance Sheet

The company has 44.41 billion in cash and 35.71 billion in debt, giving a net cash position of 8.70 billion or 111.39 per share.

Cash & Cash Equivalents	44.41B
Total Debt	35.71B
Net Cash	8.70B
Net Cash Per Share	111.39
Equity (Book Value)	113.49B
Book Value Per Share	1,452.27
Working Capital	31.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 600.88 million and capital expenditures -7.17 billion, giving a free cash flow of -6.56 billion.

Operating Cash Flow	600.88M
Capital Expenditures	-7.17B
Free Cash Flow	-6.56B
FCF Per Share	-84.01

Full Cash Flow Statement

Margins

Gross margin is 27.62%, with operating and profit margins of 1.09% and 17.10%.

Gross Margin	27.62%
Operating Margin	1.09%
Pretax Margin	-4.67%
Profit Margin	17.10%
EBITDA Margin	4.75%
EBIT Margin	1.09%
FCF Margin	n/a

Dividends & Yields

Kyung Nam Pharm does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.38%
Shareholder Yield	-52.38%
Earnings Yield	17.15%
FCF Yield	-11.72%

Stock Splits

The last stock split was on December 13, 2013. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 13, 2013
Split Type	Reverse
Split Ratio	0.2

Scores

Kyung Nam Pharm has an Altman Z-Score of 0.96 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.96
Piotroski F-Score	5